Figure 2.

The involvement of the endocannabinoid (EC) system over-activity in the pathophysiology of the metabolic syndrome. Adapted from [20] and [17].

Tibiriça Diabetology & Metabolic Syndrome 2010 2:5   doi:10.1186/1758-5996-2-5
Download authors' original image